If you need more lookups,
subscriptions start at $34 USD/month.
Philip Chung Location
South Korea
Philip Chung Work
Senior Research Scientist, New Modality Center @ (August 2026 - Present)
Senior Research Scientist, Innovation Center @ (May 2025 - August 2026)
Scientist II, Target and Exploratory Biology @ Chinook Therapeutics, a Novartis Company (March 2023 - August 2024)
Senior Scientist, New Biologics @ (December 2019 - March 2023)
Scientist @ (August 2019 - December 2019)
PhD Graduate Student @ (September 2010 - June 2019)
PhD Graduate Student @ (September 2010 - June 2019)
Philip Chung Education
University of Toronto
Doctor of Philosophy (Ph.D.) (Laboratory Medicine & Pathobiology)
University of Toronto at Mississauga - Erindale College
HBS (Biology)
Philip Chung Skills
Design of Experiments (DOE)
ELISA
Assay Development
Cell Biology
Molecular Biology
Scientific Writing
Animal Models
Research
Cancer Research
Cancer
Immunohistochemistry
Microscopy
Tissue Culture
Stem Cells
Molecular Cloning
Life Sciences
Philip Chung Summary
Philip Chung, based in South Korea, is currently a Senior Research Scientist, New Modality Center at LigaChem Biosciences. Philip Chung brings experience from previous roles at LigaChem Biosciences, Chinook Therapeutics, a Novartis Company and Kanaph therapeutics. Philip Chung holds a Doctor of Philosophy (Ph.D.) in Laboratory Medicine & Pathobiology @ University of Toronto. With a robust skill set that includes Design of Experiments (DOE), ELISA, Assay Development, Cell Biology, Molecular Biology and more. Philip Chung has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Philip Chung?
Find contact details for 700 million professionals.